Loading...
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Background: Breast cancer patients with residual disease after neoadjuvant chemotherapy (NAC) have increased recurrence risk. Molecular characterization, knowledge of NAC response, and simultaneous generation of patient-derived xenografts (PDXs) may accelerate drug development. However, the feasibil...
Na minha lista:
| Udgivet i: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408989/ https://ncbi.nlm.nih.gov/pubmed/28376176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw306 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|